Share Name Share Symbol Market Type Share ISIN Share Description
Sinclair Pharma LSE:SPH London Ordinary Share GB0033856740 ORD 1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  +0.25p +1.14% 22.25p 22.00p 22.50p - - - 32,789 16:35:20
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Pharmaceuticals & Biotechnology 45.5 -38.2 -5.9 - 112.09

Sinclair Pharma Share Discussion Threads

Showing 1826 to 1850 of 1850 messages
Chat Pages: 74  73  72  71  70  69  68  67  66  65  64  63  Older
DateSubjectAuthorDiscuss
11/2/2018
12:09
Mmm it seems at the lower end of the range so I agree it looks like a sell.
red ninja
10/2/2018
19:04
It comes up as a sell on Level II but I’ve had buy orders showing up in red so I’ll take it as a buy,hopefully see a strong rally for the markets Monday,I’m sure that massive spike down in the US was caused by traders/funds just clearing all their holdings, winners & losers together to try & balance the books, rather than taking a massive hit just on the losers,I’ve done it myself, pure panic thinking everything is just tanking & then having to buy back in at a higher price the next week,it’s good to have the markets moving again.
mercer95
10/2/2018
13:50
Someone bought 206,860 shares yesterday `O` trade, nice to see.
dealit
02/2/2018
19:28
Cheers dealit, I’m still confident, have a good weekend
mercer95
02/2/2018
15:31
Do not get your hopes up too much, modest expectations.
stalbans66
02/2/2018
14:39
IMHO feel it is a buy, the price paid is 23.15p the sell price below was 22.88p a buy of 5m+ would be discounted anyway something brewing I hope. I topped up on Wednesday did not spend a million pound though.
dealit
02/2/2018
10:12
Dealit, big trade just went through, wasn’t me, was it you lol what do think, a buy or sell
mercer95
26/1/2018
15:36
Lol,you’re not wrong dealit, profit would give me laughter lines & I’ll happily live with them
mercer95
26/1/2018
15:23
The word `profit` will get rid of these lines IMHO.
dealit
26/1/2018
10:28
21 March next update, I bought another 38800 earlier but that’s my lot for now or I’ll be needing a face lift to get rid of my worry lines if the numbers are weak
mercer95
25/1/2018
17:43
Hi dealit, yes, did my research, I bought in two days ago, one for the back burner but I’m definitely holding out for the results, I’ll add if the volumes pick up, SPH streamlined their product range but I reckon the thread lift procedure, I thinks it’s called silhouette will be a big winner on results day, just a case of wait & see now but it’s good to know someone else can see the potential in Sinclair, good luck to us, cheers dealit
mercer95
25/1/2018
16:05
Hi Mercer95, if you have done your research before buying and concluded that SPH should be doing better I agree. SPH do tend to promise jam tomorrow rather a lot. The results are due out in March let us hope the jam arrives this time.
dealit
24/1/2018
11:22
I bought in, love the product, don’t use it myself but women are mad for it, growth industry, directors bought in around these levels
mercer95
20/1/2018
10:53
Mmm found it hard to believe the Peel Hunt 68p target, not really convinced by their 48p target either.
red ninja
18/1/2018
13:46
Peel Hunt (IMO not the greatest co.) have dropped tp 68p down to 48p. Nothing from Soros lot or Tosca etc. Publicly that is!
eggbaconandbubble
17/1/2018
19:47
Let us hope that the share price moves steadily North now until the results in March, 30p+ would be nice IMHO.
dealit
17/1/2018
09:17
Looks inspiring. Prelude to cash call?
cumnor
17/1/2018
09:03
Exited some time ago - don't feel any rush to get back in despite director buys......... Sub 20p would see me adding an initial stake......all about the cash burn.....one or two concerns over the trading (US Silhouette) too....... There will be a few companies keeping a watchful eye here but better let SPH do the hard work/stump up the dosh for now.......
soundbuy
17/1/2018
07:18
Another Director buying 200,000 announced today, all very positive indeed.
dealit
16/1/2018
20:22
H1 loss adjusted EBITDA 1.7m. H2 ADJUSTED EBITDA MORETHAN POSITIVE EBITDA OF £1.7M Todays announcement together will full year of better margin on products and momentum into 2018 indicates reasonable chance of good Q1 sales in 2018 with FY results.
zipstuck
16/1/2018
19:58
Peel Hunt have 68p and reiterate, yesterday. I have always thought these may get bought and at this share price Sinclair would be cheap IMHO.
dealit
16/1/2018
19:43
Numis brokers have hold and 21p target on Sinclair Pharma according to interactive investor website
red ninja
16/1/2018
18:53
Mmmmm....not quite as simple as that! Fixed overheads are also cash burn. By increasing turnover the fixed overhead per unit drops, making the whole operation more cost effective/profitable. Sure marketing costs money but accelerates the rate of increase in turnover. I don't think SPH which has at present cutting edge technology in Silhouette etc. has the luxury of time to grow too slowly as there will always be the danger of that technology being superseded. SPH marketing at present appears to be aimed at the doctors and practitioners. Creating demand by marketing to the end user may be a lot more cost effective. Botox is a word on everyone's lips. I don't think Silhouette is!
eggbaconandbubble
16/1/2018
16:22
Problem is marketing = cash burn.
eastbourne1982
16/1/2018
16:02
Everything is in place here. Now they need large increases in turnover. To achieve that they need to look very hard at their marketing.
eggbaconandbubble
Chat Pages: 74  73  72  71  70  69  68  67  66  65  64  63  Older
Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P:40 V: D:20180219 01:51:52